Ischemia-reperfusion injury after lung transplantation;Lésions d'ischémie-reperfusion en transplantation pulmonaire

Presse Medicale

Volumn 43, Issue 9, 2014, Pages 921-930

  Gennai, Stéphane ^a,b   Pison, Christophe ^c   Briot, Raphaël ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b LABORATOIRE TIMC IMAG   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; SODIUM; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; BRONCHODILATING AGENT; CARBON MONOXIDE; CARRIER PROTEIN; CYTOKINE; LUNG SURFACTANT; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

CALCIUM CELL LEVEL; CELL DEATH; CLINICAL PRACTICE; DISEASE ASSOCIATION; GRAFT DYSFUNCTION; HUMAN; LUNG DISEASE; LUNG ISCHEMIA REPERFUSION INJURY; LUNG TRANSPLANTATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SHORT SURVEY; TREATMENT RESPONSE; APOPTOSIS; ARTIFICIAL VENTILATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LUNG ALVEOLUS; METABOLISM; METHODOLOGY; ORGAN PRESERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION; REPERFUSION INJURY; REVIEW; SEVERITY OF ILLNESS INDEX; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; BRONCHODILATOR AGENTS; CALCIUM; CARBON MONOXIDE; CYTOKINES; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LUNG TRANSPLANTATION; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NADPH OXIDASE; NITRIC OXIDE; ORGAN PRESERVATION; OXIDATIVE STRESS; OXYGEN; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; REACTIVE OXYGEN SPECIES; REPERFUSION; REPERFUSION INJURY; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84908297455     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.01.018     Document Type: Short Survey

References (30)

1. International Society for Heart and Lung Transplantation Transplant Registry 2014, [Access 14/04/2014]. http://www.ishlt.org/.
2. Agence de la biomédecine Rapport médical et scientifique de l'agence de la biomédecine 2011-2012. Greffe cardiopulmonaire et pulmonaire 2014, [Access 14/04/2014]. http://www.agence-biomedecine.fr/annexes/bilan2012/donnees/organes/04-coeur-poumon/synthese.htm.
3. de Perrot M., Liu M., Waddell T.K., Keshavjee S. State of the art. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003, 167:490-511.
4. Al Mehdi A.B., Zhao G., Dodia C., Tozawa K., Costa K., Muzykantov V., et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or K+. Circ Res 1998, 83:730-737.
5. Le Cras T.D., McMurtry I.F. Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol 2001, 280:L575-L582.
6. Gateau-Roesch O., Argaud L., Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006, 70:264-273.
7. Briot R., Frank J.A., Uchida T., Lee J.W., Calfee C.S., Matthay M.A. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009, 135:269-275.
8. Geudens N., Van De Wauwer C., Neyrinck A.P., Timmermans L., Vanhooren H.M., Vanaudenaerde B.M., et al. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant 2007, 26:1326-1332.
9. Chiang C.H., Wu K., Yu C.P., Yan H.C., Perng W.C., Wu C.P. Hypothermia and prostaglandin E(1) produce synergistic attenuation of ischemia-reperfusion lung injury. Am J Respir Crit Care Med 1999, 160:1319-1323.
10. Schütte H., Schell A., Schäfer C., Ghofrani A., Theo Schermuly R., Seeger W., et al. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion. Transplantation 2003, 75:814-821.
11. Struber M., Hirt S.W., Cremer J., Harringer W., Haverich A. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 1999, 25:862-864.
12. Ambros J.T., Herrero-Fresneda I., Borau O.G., Boira J.M. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 2007, 20:219-229.
13. Steen S., Kimblad P.O., Sjoberg T., Lindberg L., Ingemansson R., Massa G. Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg 1994, 57:450-457.
14. Roe D.W., Fehrenbacher J.W., Niemeier M.R., Zieger M., Labarrere C., Wilkes D.S. Lung preservation: pulmonary flush route affects bronchial mucosal temperature and expression of IFN-gamma and Gro in regional lymph nodes. Am J Transplant 2005, 5:995-1001.
15. Haverich A., Aziz S., Scott W.C., Jamieson S.W., Shumway N.E. Improved lung preservation using Euro-Collins solution for flush-perfusion. Thorac Cardiovasc Surg 1986, 34:368-376.
16. Sakuma T., Tsukano C., Ishigaki M., Nambu Y., Osanai K., Toga H., et al. Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs. Transplantation 2000, 69:1785-1793.
17. de Perrot M., Fischer S., Liu M., Jin R., Bai X.H., Waddell T.K., et al. Prostaglandin E1protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 2001, 72:1505-1512.
18. Zamora M.R., Davis R.D., Keshavjee S.H., Schulman L., Levin J., Ryan U., et al. Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial. Chest 1999, 116:46S.
19. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998, 97:276-281.
20. Rozé H., Thumerel M., Barandon L., Dromer C., Perrier V., Jougon J., et al. Cardiopulmonary bypass during a second-lung implantation improves postoperative oxygenation after sequential double-lung transplantation. J Cardiothorac Vasc Anesth 2013, 27:467-473.
21. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
22. Diamond J.M., Lee J.C., Kawut S.M., Shah R.J., Localio A.R., Bellamy S.L., et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013, 187:527-534.
23. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001, 357:825-829.
24. Cypel M., Yeung J.C., Liu M., Anraku M., Chen F., Karolak W., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011, 364:1431-1440.
25. Inci I., Zhai W., Arni S., Hillinger S., Vogt P., Weder W. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg 2007, 84:240-246.
26. Frank J.A., Briot R., Lee J.W., Ishizaka A., Uchida T., Matthay M.A. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007, 293:L52-L59.
27. Cypel M., Liu M., Rubacha M., Yeung J.C., Hirayama S., Anraku M., et al. Functional repair of human donor lungs by IL-10gene therapy. Sci Transl Med 2009, 1:4ra9.
28. Lee J.W., Fang X., Gupta N., Serikov V., Matthay M.A. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009, 106:16357-16362.
29. Cottini S.R., Wenger U., Sailer S., Stehberger P.A., Schuepbach R.A., Hasenclever P., et al. Extracorporeal membrane oxygenation: beneficial strategy for lung transplant recipients. J Extra Corpor Technol 2013, 45:16-20.
30. Gennai S., Souilamas R., Maignan M., Brouta A., Pison C., Fontaine E., et al. Effects of cyclosporine a in ex vivo reperfused pig lungs. Microcirculation 2014, 21:84-92.